EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tsuguo Naruke
Ryosuke Tsuchiya
Haruhiko Kondo
Haruhiko Nakayama
Hisao Asamura
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naruke, T.
Right arrow Articles by Asamura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naruke, T.
Right arrow Articles by Asamura, H.

Eur J Cardiothorac Surg 1999;16:S17-S24
© 1999 Elsevier Science NL

Lymph node sampling in lung cancer: how should it be done?

Tsuguo Naruke*, Ryosuke Tsuchiya, Haruhiko Kondo, Haruhiko Nakayama, Hisao Asamura

Division of Thoracic Surgery, National Cancer Center Hospital, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan

* Corresponding author. Tel.: +81-3-5447-2468; fax: +81-3-5447-2468

Objectives: Systematic lymph node dissection in radical operation for lung cancer is recognized as an operative procedure which is expected to improve local control. We investigate the most effective method of lymph node dissection or sampling. Methods: A retrospectrive study was carried out on 1815 patients who underwent systematic lymph node dissection and complete resection. The lymphatic route of metastatis from each lobe was investigated by examining which nodes had the most likelihood of metastasis, or to find out which is the sentinel lymph node in the case of small sized tumor, suitable for the video assisted thoracic surgery (VATS) approach. Results: At N2 level, distribution of major metastases from each lobe are as follows: right upper lobe tumor, 3 – 12.3% (80/648) and/or 4 – 8% (52/648); right middle lobe tumor, 3 and/or 7 – 16.4% (13/79); right lower lobe tumor, 7 – 13.7% (52/380); left upper lobe tumor, 5 – 12.3% (60/489) and/or 6 – 6.7% (33/489); and left lower lobe tumor, 7 – 11.9% (26/219). Small sized tumor requires lymph node sampling upon staging, and the lymph node most likely to become the first metastasis, i.e. sentinel node, are as follows: regardless of the location of tumor, 12, 11, and/or 10 in N1 level, which means dissection or sampling within these locations of lymph nodes are prerequisite. In N2 level, 3 and/or 4 in right upper lobe tumor, 3 and/or 7 in right middle lobe tumor, 7 in right lower lobe tumor, 5 and/or 6 in left upper lobe tumor, and, 7 in left lower lobe tumor. Conclusions: In clinical T1NO lung cancer, sentinel lymph node sampling should be done first, if the nodes are negative, complete mediastinal lymph node dissection might be omitted. On the other hand, if the sentinel nodes are positive for pathology, complete medistinal lymph node dissection is required for curative resection.

Key Words: Lymph node sampling • Sentinel lymph node • Lung cancer • Systematic nodal dissection







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.